EMAIL THIS PAGE TO A FRIEND

Oncotarget

Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.


PMID 26036626

Abstract

Prostate cancer progression to castration refractory disease is associated with anomalous transcriptional activity of the androgen receptor (AR) in an androgen-depleted milieu. To identify novel gene products whose downregulation transactivates AR in prostate cancer cells, we performed a screen of enzymatically-generated shRNA lenti-libraries selecting for transduced LNCaP cells with elevated expression of a fluorescent reporter gene under the control of an AR-responsive promoter. The shRNAs present in selected populations were analyzed using high-throughput sequencing to identify target genes. Highly enriched gene targets were then validated with siRNAs against selected genes, testing first for increased expression of luciferase from an AR-responsive promoter and then for altered expression of endogenous androgen-regulated genes in LNCaP cells. We identified 20 human genes whose silencing affected the expression of exogenous and endogenous androgen-responsive genes in prostate cancer cells grown in androgen-depleted medium. Knockdown of four of these genes upregulated the expression of endogenous AR targets and siRNAs targeting two of these genes (IGSF8 and RTN1) enabled androgen-independent proliferation of androgen-dependent cells. The effects of IGSF8 appear to be mediated through its interaction with a tetraspanin protein, CD9, previously implicated in prostate cancer progression. Remarkably, homozygous deletions of IGSF8 are found almost exclusively in prostate cancers but not in other cancer types. Our study shows that androgen independence can be achieved through the inhibition of specific genes and reveals a novel set of genes that regulate AR signaling in prostate cancers.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4500944
Anti-AKR1B1, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB1300902
Anti-APS (center) antibody produced in rabbit, saturated ammonium sulfate (SAS) precipitated, buffered aqueous solution
SAB1405474
Anti-KLK3 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA000764
Anti-KLK3 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1410703
Anti-KLK3 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB4501649
Anti-KLKB1 (heavy chain, Cleaved-Arg390) antibody produced in rabbit, affinity isolated antibody
HPA005634
Anti-KLKB1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV45678
Anti-KLKB1 antibody produced in rabbit, IgG fraction of antiserum
SAB2106715
Anti-KLKB1 antibody produced in rabbit, affinity isolated antibody
SAB4501531
Anti-Prostate-specific Antigen antibody produced in rabbit, affinity isolated antibody
SAB1303590
ANTI-PSA (C-TERM) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
WH0000354M2 Monoclonal Anti-KLK3 antibody produced in mouse, clone 1B1, purified immunoglobulin, buffered aqueous solution
SAB5300268
Monoclonal Anti-KLK3 antibody produced in mouse, clone 5A11E9, ascites fluid
R0908
R1881, ≥98% (HPLC)
C19H24O2